Cardiovascular Risk Management

ACC: Coronary Artery Calcium Progression May Accelerate After Menopause

Authors say sharp increase in cardiovascular risk warrants more regular screening Postmenopausal changes may accelerate coronary artery calcium (CAC) progression in women, according to a study presented at the annual meeting of the American College of Cardiology, held from April 6 to 8 in Atlanta. Ella Ishaaya, M.D., from Harbor-UCLA Medical Center in Torrance, California,...

Long-Term Efficacy and Safety of Evinacumab in Refractory Hypercholesterolemia Patients

Evinacumab was found to be safe and well-tolerated and was associated with a sustained reduction in the levels of low-density lipoprotein cholesterol in patients diagnosed with refractory hypercholesterolemia. Individuals diagnosed with refractory hypercholesterolemia do not achieve the target levels of low-density lipoprotein cholesterol (LDL-C) despite lipid-lowering treatment at maximally tolerated dosages. These refractory hypercholesterolemia patients...

Percentage Reduction in Low-Density Lipoprotein Cholesterol and Stroke Prevention

For the strategy of targeting low-density lipoprotein cholesterol to less than 70 mg/dL, patients with >50% reduction from baseline but not patients with <50% reduction from baseline showed superior stroke risk reduction when compared to a target level of 100 ± 10 mg/dL. The Treat Stroke-to-Target (TST) trial findings indicate the superiority of targeting low-density...

Plasma Atorvastatin Metabolite Levels Correlate With Low-Density Lipoprotein Cholesterol Reduction

The trough plasma concentration of atorvastatin metabolites has a moderate correlation with a decrease in the levels of low-density lipoprotein cholesterol, according to the results of a randomized double‐blind crossover trial. Atorvastatin metabolites hold potential value in monitoring and optimizing the drug dosage for optimal clinical efficacy.    Statins form the standard treatment in the primary...

Rosuvastatin Versus Atorvastatin Treatment in Adults With Coronary Artery Disease

Rosuvastatin and atorvastatin were comparable in terms of all-cause death, coronary revascularization, myocardial infarction, or stroke at 3 years of intervention in a randomized prospective trial. However, rosuvastatin administration was related to comparatively lower levels of low-density lipoprotein cholesterol and a higher risk for cataract surgery and antidiabetic treatment. Statins are known to be effective...

Cardiometabolic Effects of Omnivorous Versus Vegan Diets in Identical Twins

Compared to a healthy omnivorous diet, a healthy vegan diet was associated with improved cardiometabolic parameters, including decreases in low-density lipoprotein cholesterol levels, fasting insulin levels, and body weight in an 8-week study of identical twins. Dietary patterns with high plant-based and low animal-based foods are associated with positive health and environmental outcomes. A well-formulated...

Treat-to-Target or High-Intensity Statins in Patients With Coronary Artery Disease

The 3-year composite of death, myocardial infarction, coronary revascularization, and stroke outcomes were comparable between treat-to-target and high-intensity statins in coronary artery disease patients in a recent randomized trial. Coronary artery disease (CAD) is associated with an increased risk for adverse cardiovascular events. Studies have recommended statin therapy for reducing the levels of low-density lipoprotein...

Calcium, Vitamin D Supplements May Reduce Cancer Mortality in Long Term

But increase in cardiovascular disease mortality seen after more than 20 years of follow-up among older women For postmenopausal women, calcium and vitamin D (CaD) supplements may reduce cancer mortality and increase cardiovascular disease (CVD) mortality after more than 20 years of follow-up, according to a study published online March 12 in the Annals of Internal...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.